In an interview with Jornal de Notícias, João Fonseca, a researcher at CINTESIS@RISE/Faculty of medicine of the university of Porto (FMUP), spoke about the potential transformation of asthma treatment following the publication of the results of a new clinical trial in the journal “Lancet Respiratory Medicine”.
The coordinator of Epi-Asthma, which focused on the reality of asthma in Portugal, believes that this study could be “transformative”, firstly because it offers personalized therapy to asthma patients. In addition, it could reduce the use of corticosteroids, avoiding their side effects.
Read more